EV Battery Maker Expects Revenue to Rise 35-45% in 2022

Source: Streetwise Reports   05/17/2022 

Shares of EV Li-ion battery manufacturer Microvast Holdings Inc. traded 16% higher after the company reported Q1/22 financial results highlighting a 145% YoY revenue increase.

Late yesterday afternoon, ultra-fast charging EV battery maker Microvast Holdings Inc. (MVST:NASDAQ), which is focused on designing, developing, and manufacturing innovative lithium-ion battery solutions, announced unaudited financial results for the first quarter of 2022 ended March 31, 2022.

The company’s CFO, Craig Webster, led off the report by stating, “Our first-quarter revenue performance exceeded our expectations, and our order book looks very strong…Looking forward, we are focused on sales growth throughout the year, growing our multi-year order book, and executing on our capacity expansion plans, which are well underway and fully funded from our cash on hand.”

Microvast’s President and Chief Revenue Officer Sascha Kelterborn commented, “Overall, I’m pleased with the strong 145.5% revenue growth we posted in Q1/22 and the progress we continue to make on the expansion of our international business.”

“We had an excellent revenue quarter in the Asia Pacific region (excluding China), fueled by significant growth in India, and orders from our multi-year European projects were strong across our new recently-announced battery solutions specifically designed for the commercial vehicle market,” Kelterborn added.

The company reported that during Q1/22, total revenue increased by 145.5% to $36.7 million, compared to $14.9 million in Q1/21.

The firm stated that in Q1/22, gross profit improved significantly to $13.0 thousand, compared to a gross loss of $1.2 million in Q1/21, and added that during Q1/22, adjusted gross profit rose to $1.9 million, versus an adjusted gross loss of $1.2 million in Q1/21, which represented a 13.5% year-over-year improvement.

The company advised that for Q1/22, it recorded a net loss of $43.8 million versus a net loss of $16.3 million in Q1/21.

The company confirmed its prior revenue estimates for FY/22, which call for year-over-year revenue growth of 35-45%. The company noted that the firm’s ability to reach these levels could be adversely impacted if overall macro conditions such as inflation, supply chain disruptions, China COVID restrictions, and the Ukraine situation worsens.

Microvast listed that its backlog as of the end of Q1/22 grew by 85.6% to $120.8 million, compared to $65.1 million at the end of Q1/21. The firm noted that it remains greatly optimistic regarding prospects for additional incoming orders over the rest of FY/22.

The firm noted that it expects to make capital expenditures of $300-350 million in FY/22. The company advised that the investment will be used to continue the expansion of manufacturing capacity at its operations in Huzhou, China, and Clarksville, Tenn. Microvast stated that these expenditures will result in adding 4 GWh of annual capacity and will target higher production of larger format battery cells.

Microvast Holdings is a designer, developer, and manufacturer of ultra-fast charging lithium-ion batterie for use in electric vehicles (EVs) and energy storage systems. The company claims that “it is renowned for its cutting-edge cell technology and its vertical integration capabilities which extend from core battery chemistry (cathode, anode, electrolyte, and separator) to modules and packs.” Microvast is headquartered in Stafford, Tex. and since it was first established in 2006, its Li-ion batteries have been integrated into over 30,000 vehicles in 19 countries and have racked up more than 3.8 billion traveled miles.

Microvast Holdings started the day with a market cap of around $1.0 billion with approximately 300.5 million shares outstanding and a short interest of about 5.8%. MVST shares opened 17.5% higher today at $3.95 (+$0.59, +17.56%) over yesterday’s $3.36 closing price. The stock has traded today between $3.78 and $4.31 per share and is currently trading at $3.89 (+$0.53, +15.77%).

Disclosure:
1) Stephen Hytha compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. He or members of his household own securities of the following companies mentioned in the article: None. He or members of his household are paid by the following companies mentioned in this article: None.

2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.

3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.

4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional, and any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice, and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services, or securities of any company mentioned on Streetwise Reports.

5) From time to time, Streetwise Reports LLC and its directors, officers, employees, or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in the securities mentioned. Directors, officers, employees, or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the decision to publish an article until three business days after the publication of the article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases.